High-sensitivity cardiac troponin T is associated with disease activity in patients with inflammatory arthritis
To investigate whether high-sensitivity cardiac troponin T (hsTnT) correlates to markers of disease activity in inflammatory arthritis (IA), and whether antirheumatic treatment influences hsTnT levels. We assessed 115 patients with active IA (64 rheumatoid arthritis (RA), 31 psoriatic arthritis and...
Saved in:
| Published in | PloS one Vol. 18; no. 2; p. e0281155 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Public Library of Science
10.02.2023
PLOS Public Library of Science (PLoS) |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1932-6203 1932-6203 |
| DOI | 10.1371/journal.pone.0281155 |
Cover
| Abstract | To investigate whether high-sensitivity cardiac troponin T (hsTnT) correlates to markers of disease activity in inflammatory arthritis (IA), and whether antirheumatic treatment influences hsTnT levels.
We assessed 115 patients with active IA (64 rheumatoid arthritis (RA), 31 psoriatic arthritis and 20 ankylosing spondylitis) before and after using methotrexate (MTX) alone or tumor necrosis factor inhibitor (TNFi) with or without MTX co-medication (TNFi±MTX). All patients starting with TNFi had been previously unsuccessfully treated with MTX monotherapy. HsTnT (measured in serum by electro-chemiluminescence immunoassay (Roche Elecsys® Troponin T- high-sensitivity)), and other clinical and laboratory parameters were evaluated at baseline, and after 6 weeks and 6 months of treatment.
Of markers of disease activity, baseline levels of hsTnT positively correlated with Physicians' Global Assessment Score of disease activity in the total patient cohort (p = 0.039). In RA group, hsTnT positively correlated with swollen joints, Disease Activity Score for 28 joints with ESR and serum tumor necrosis factor levels (p = 0.025, p = 0.008, p = 0.01, respectively). Median hsTnT at baseline was 5.0 ng/L, and did not change significantly at 6-week visit (6.0 ng/L, p = 0.37) and 6-month visit (6.0 ng/L, p = 0.18) with either antirheumatic therapy.
HsTnT levels were associated with inflammatory markers for IA disease activity. However, while inflammatory markers significantly improved after antirheumatic treatment, hsTnT did not change during the 6-month follow-up period. |
|---|---|
| AbstractList | To investigate whether high-sensitivity cardiac troponin T (hsTnT) correlates to markers of disease activity in inflammatory arthritis (IA), and whether antirheumatic treatment influences hsTnT levels. We assessed 115 patients with active IA (64 rheumatoid arthritis (RA), 31 psoriatic arthritis and 20 ankylosing spondylitis) before and after using methotrexate (MTX) alone or tumor necrosis factor inhibitor (TNFi) with or without MTX co-medication (TNFi±MTX). All patients starting with TNFi had been previously unsuccessfully treated with MTX monotherapy. HsTnT (measured in serum by electro-chemiluminescence immunoassay (Roche Elecsys® Troponin T- high-sensitivity)), and other clinical and laboratory parameters were evaluated at baseline, and after 6 weeks and 6 months of treatment. Of markers of disease activity, baseline levels of hsTnT positively correlated with Physicians' Global Assessment Score of disease activity in the total patient cohort (p = 0.039). In RA group, hsTnT positively correlated with swollen joints, Disease Activity Score for 28 joints with ESR and serum tumor necrosis factor levels (p = 0.025, p = 0.008, p = 0.01, respectively). Median hsTnT at baseline was 5.0 ng/L, and did not change significantly at 6-week visit (6.0 ng/L, p = 0.37) and 6-month visit (6.0 ng/L, p = 0.18) with either antirheumatic therapy. HsTnT levels were associated with inflammatory markers for IA disease activity. However, while inflammatory markers significantly improved after antirheumatic treatment, hsTnT did not change during the 6-month follow-up period. Objective To investigate whether high-sensitivity cardiac troponin T (hsTnT) correlates to markers of disease activity in inflammatory arthritis (IA), and whether antirheumatic treatment influences hsTnT levels. Methods We assessed 115 patients with active IA (64 rheumatoid arthritis (RA), 31 psoriatic arthritis and 20 ankylosing spondylitis) before and after using methotrexate (MTX) alone or tumor necrosis factor inhibitor (TNFi) with or without MTX co-medication (TNFi±MTX). All patients starting with TNFi had been previously unsuccessfully treated with MTX monotherapy. HsTnT (measured in serum by electro-chemiluminescence immunoassay (Roche Elecsys® Troponin T- high-sensitivity)), and other clinical and laboratory parameters were evaluated at baseline, and after 6 weeks and 6 months of treatment. Results Of markers of disease activity, baseline levels of hsTnT positively correlated with Physicians' Global Assessment Score of disease activity in the total patient cohort (p = 0.039). In RA group, hsTnT positively correlated with swollen joints, Disease Activity Score for 28 joints with ESR and serum tumor necrosis factor levels (p = 0.025, p = 0.008, p = 0.01, respectively). Median hsTnT at baseline was 5.0 ng/L, and did not change significantly at 6-week visit (6.0 ng/L, p = 0.37) and 6-month visit (6.0 ng/L, p = 0.18) with either antirheumatic therapy. Conclusions HsTnT levels were associated with inflammatory markers for IA disease activity. However, while inflammatory markers significantly improved after antirheumatic treatment, hsTnT did not change during the 6-month follow-up period. To investigate whether high-sensitivity cardiac troponin T (hsTnT) correlates to markers of disease activity in inflammatory arthritis (IA), and whether antirheumatic treatment influences hsTnT levels.OBJECTIVETo investigate whether high-sensitivity cardiac troponin T (hsTnT) correlates to markers of disease activity in inflammatory arthritis (IA), and whether antirheumatic treatment influences hsTnT levels.We assessed 115 patients with active IA (64 rheumatoid arthritis (RA), 31 psoriatic arthritis and 20 ankylosing spondylitis) before and after using methotrexate (MTX) alone or tumor necrosis factor inhibitor (TNFi) with or without MTX co-medication (TNFi±MTX). All patients starting with TNFi had been previously unsuccessfully treated with MTX monotherapy. HsTnT (measured in serum by electro-chemiluminescence immunoassay (Roche Elecsys® Troponin T- high-sensitivity)), and other clinical and laboratory parameters were evaluated at baseline, and after 6 weeks and 6 months of treatment.METHODSWe assessed 115 patients with active IA (64 rheumatoid arthritis (RA), 31 psoriatic arthritis and 20 ankylosing spondylitis) before and after using methotrexate (MTX) alone or tumor necrosis factor inhibitor (TNFi) with or without MTX co-medication (TNFi±MTX). All patients starting with TNFi had been previously unsuccessfully treated with MTX monotherapy. HsTnT (measured in serum by electro-chemiluminescence immunoassay (Roche Elecsys® Troponin T- high-sensitivity)), and other clinical and laboratory parameters were evaluated at baseline, and after 6 weeks and 6 months of treatment.Of markers of disease activity, baseline levels of hsTnT positively correlated with Physicians' Global Assessment Score of disease activity in the total patient cohort (p = 0.039). In RA group, hsTnT positively correlated with swollen joints, Disease Activity Score for 28 joints with ESR and serum tumor necrosis factor levels (p = 0.025, p = 0.008, p = 0.01, respectively). Median hsTnT at baseline was 5.0 ng/L, and did not change significantly at 6-week visit (6.0 ng/L, p = 0.37) and 6-month visit (6.0 ng/L, p = 0.18) with either antirheumatic therapy.RESULTSOf markers of disease activity, baseline levels of hsTnT positively correlated with Physicians' Global Assessment Score of disease activity in the total patient cohort (p = 0.039). In RA group, hsTnT positively correlated with swollen joints, Disease Activity Score for 28 joints with ESR and serum tumor necrosis factor levels (p = 0.025, p = 0.008, p = 0.01, respectively). Median hsTnT at baseline was 5.0 ng/L, and did not change significantly at 6-week visit (6.0 ng/L, p = 0.37) and 6-month visit (6.0 ng/L, p = 0.18) with either antirheumatic therapy.HsTnT levels were associated with inflammatory markers for IA disease activity. However, while inflammatory markers significantly improved after antirheumatic treatment, hsTnT did not change during the 6-month follow-up period.CONCLUSIONSHsTnT levels were associated with inflammatory markers for IA disease activity. However, while inflammatory markers significantly improved after antirheumatic treatment, hsTnT did not change during the 6-month follow-up period. ObjectiveTo investigate whether high-sensitivity cardiac troponin T (hsTnT) correlates to markers of disease activity in inflammatory arthritis (IA), and whether antirheumatic treatment influences hsTnT levels.MethodsWe assessed 115 patients with active IA (64 rheumatoid arthritis (RA), 31 psoriatic arthritis and 20 ankylosing spondylitis) before and after using methotrexate (MTX) alone or tumor necrosis factor inhibitor (TNFi) with or without MTX co-medication (TNFi±MTX). All patients starting with TNFi had been previously unsuccessfully treated with MTX monotherapy. HsTnT (measured in serum by electro-chemiluminescence immunoassay (Roche Elecsys® Troponin T- high-sensitivity)), and other clinical and laboratory parameters were evaluated at baseline, and after 6 weeks and 6 months of treatment.ResultsOf markers of disease activity, baseline levels of hsTnT positively correlated with Physicians' Global Assessment Score of disease activity in the total patient cohort (p = 0.039). In RA group, hsTnT positively correlated with swollen joints, Disease Activity Score for 28 joints with ESR and serum tumor necrosis factor levels (p = 0.025, p = 0.008, p = 0.01, respectively). Median hsTnT at baseline was 5.0 ng/L, and did not change significantly at 6-week visit (6.0 ng/L, p = 0.37) and 6-month visit (6.0 ng/L, p = 0.18) with either antirheumatic therapy.ConclusionsHsTnT levels were associated with inflammatory markers for IA disease activity. However, while inflammatory markers significantly improved after antirheumatic treatment, hsTnT did not change during the 6-month follow-up period. Objective To investigate whether high-sensitivity cardiac troponin T (hsTnT) correlates to markers of disease activity in inflammatory arthritis (IA), and whether antirheumatic treatment influences hsTnT levels. Methods We assessed 115 patients with active IA (64 rheumatoid arthritis (RA), 31 psoriatic arthritis and 20 ankylosing spondylitis) before and after using methotrexate (MTX) alone or tumor necrosis factor inhibitor (TNFi) with or without MTX co-medication (TNFi±MTX). All patients starting with TNFi had been previously unsuccessfully treated with MTX monotherapy. HsTnT (measured in serum by electro-chemiluminescence immunoassay (Roche Elecsys® Troponin T- high-sensitivity)), and other clinical and laboratory parameters were evaluated at baseline, and after 6 weeks and 6 months of treatment. Results Of markers of disease activity, baseline levels of hsTnT positively correlated with Physicians’ Global Assessment Score of disease activity in the total patient cohort (p = 0.039). In RA group, hsTnT positively correlated with swollen joints, Disease Activity Score for 28 joints with ESR and serum tumor necrosis factor levels (p = 0.025, p = 0.008, p = 0.01, respectively). Median hsTnT at baseline was 5.0 ng/L, and did not change significantly at 6-week visit (6.0 ng/L, p = 0.37) and 6-month visit (6.0 ng/L, p = 0.18) with either antirheumatic therapy. Conclusions HsTnT levels were associated with inflammatory markers for IA disease activity. However, while inflammatory markers significantly improved after antirheumatic treatment, hsTnT did not change during the 6-month follow-up period. To investigate whether high-sensitivity cardiac troponin T (hsTnT) correlates to markers of disease activity in inflammatory arthritis (IA), and whether antirheumatic treatment influences hsTnT levels. We assessed 115 patients with active IA (64 rheumatoid arthritis (RA), 31 psoriatic arthritis and 20 ankylosing spondylitis) before and after using methotrexate (MTX) alone or tumor necrosis factor inhibitor (TNFi) with or without MTX co-medication (TNFi±MTX). All patients starting with TNFi had been previously unsuccessfully treated with MTX monotherapy. HsTnT (measured in serum by electro-chemiluminescence immunoassay (Roche Elecsys® Troponin T- high-sensitivity)), and other clinical and laboratory parameters were evaluated at baseline, and after 6 weeks and 6 months of treatment. Of markers of disease activity, baseline levels of hsTnT positively correlated with Physicians' Global Assessment Score of disease activity in the total patient cohort (p = 0.039). In RA group, hsTnT positively correlated with swollen joints, Disease Activity Score for 28 joints with ESR and serum tumor necrosis factor levels (p = 0.025, p = 0.008, p = 0.01, respectively). Median hsTnT at baseline was 5.0 ng/L, and did not change significantly at 6-week visit (6.0 ng/L, p = 0.37) and 6-month visit (6.0 ng/L, p = 0.18) with either antirheumatic therapy. HsTnT levels were associated with inflammatory markers for IA disease activity. However, while inflammatory markers significantly improved after antirheumatic treatment, hsTnT did not change during the 6-month follow-up period. |
| Audience | Academic |
| Author | Fagerland, Morten Wang Feinberg, Mark W. Agewall, Stefan Nguyen, Thao H. P. Whist, Jon Elling Hollan, Ivana |
| AuthorAffiliation | 2 Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway 1 Lillehammer Hospital for Rheumatic Diseases, Lillehammer, Norway 3 Department of Rheumatology, Oslo University Hospital, Rikshospitalet, Oslo, Norway 8 Harvard Medical School, Boston, MA, United States of America 7 Department of Laboratory medicine, Innlandet Hospital Trust, Lillehammer, Norway 4 Oslo Centre for Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital, Oslo, Norway 5 Beitostølen Health and Sport Centre, Beitostølen, Norway 10 Department of Cardiology, Oslo University Hospital, Ullevål, Oslo, Norway 6 Norwegian University of Science and Technology, Gjøvik, Norway 9 Division of Cardiology, Brigham and Women´s Hospital, Boston, MA, United States of America University of Toronto, CANADA |
| AuthorAffiliation_xml | – name: 3 Department of Rheumatology, Oslo University Hospital, Rikshospitalet, Oslo, Norway – name: 5 Beitostølen Health and Sport Centre, Beitostølen, Norway – name: 9 Division of Cardiology, Brigham and Women´s Hospital, Boston, MA, United States of America – name: 1 Lillehammer Hospital for Rheumatic Diseases, Lillehammer, Norway – name: 2 Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway – name: 10 Department of Cardiology, Oslo University Hospital, Ullevål, Oslo, Norway – name: 6 Norwegian University of Science and Technology, Gjøvik, Norway – name: 8 Harvard Medical School, Boston, MA, United States of America – name: 7 Department of Laboratory medicine, Innlandet Hospital Trust, Lillehammer, Norway – name: University of Toronto, CANADA – name: 4 Oslo Centre for Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital, Oslo, Norway |
| Author_xml | – sequence: 1 givenname: Thao H. P. orcidid: 0000-0003-2597-4031 surname: Nguyen fullname: Nguyen, Thao H. P. – sequence: 2 givenname: Morten Wang surname: Fagerland fullname: Fagerland, Morten Wang – sequence: 3 givenname: Ivana surname: Hollan fullname: Hollan, Ivana – sequence: 4 givenname: Jon Elling surname: Whist fullname: Whist, Jon Elling – sequence: 5 givenname: Mark W. surname: Feinberg fullname: Feinberg, Mark W. – sequence: 6 givenname: Stefan surname: Agewall fullname: Agewall, Stefan |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36763689$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNk2uL1DAUhousuBf9B6IFQfTDjLk0vfhBWBZ1BxYWdPVrOJOk0wxtMibp6vx7053OMl0WkUIb0ue855z3JKfJkbFGJclLjOaYFvjD2vbOQDvfxO05IiXGjD1JTnBFySwniB4drI-TU-_XCDFa5vmz5JjmRU7zsjpJ7KVeNTOvjNdB3-qwTQU4qUGkwdkorU16k2qfgvdWaAhKpr91aFKpvQKvUhBjWAQ3ELQywe8IbeoWug6CddsUXGhczOCfJ09raL16MX7Pkh9fPt9cXM6urr8uLs6vZqLARZhhkEgqkeVAlgiQxBKUIFgUtcykUoIt2RKzImMloYSpUtYgmMpRVZS0riWmZ8nrne6mtZ6PXnlOioIRgoqMRGKxI6SFNd843YHbcgua321Yt-Kxai1axUXGkCBZSbCqs5zh6LWgUNeILStV4yxqfRqz9ctOSRFdcNBORKd_jG74yt7yqsI5q6ookO4EhNM-aMONdcAxKhmJb4roUO-7MYezv3rlA--0F6ptwSjb71rLMSF3rb15gD5uwEitIPYYx2VjaWIQ5ecFzRkrKRsqmz9CxUeqTot49mod9ycB7ycBkQnqT1hB7z1ffP_2_-z1zyn79oBtFLSh8bbtg7bGT8FXh8O4n8L-0Ecg25ttvXeqvkcw4sPd2tvFh7vFx7sVwz4-CBM6wJA-OqLbfwf_BRYpKxc |
| CitedBy_id | crossref_primary_10_3390_biomedicines12112638 |
| Cites_doi | 10.1371/journal.pone.0169830 10.1136/annrheumdis-2020-217159 10.1136/bmj.k1036 10.3390/ijms22052719 10.1371/journal.pone.0253793 10.1373/clinchem.2009.132654 10.1161/CIRCULATIONAHA.110.005264 10.1002/art.1780310302 10.1002/clc.23214 10.3899/jrheum.130713 10.1038/nrrheum.2015.112 10.1093/rheumatology/key057 10.1097/RHU.0000000000000951 10.1016/j.ahj.2013.04.018 10.1016/j.atherosclerosis.2016.10.016 10.1371/journal.pone.0038930 10.1136/annrheumdis-2016-210275 10.1136/annrheumdis-2016-210770 10.3899/jrheum.110845 10.1136/annrheumdis-2019-216655 10.1016/j.clinbiochem.2019.11.013 10.3899/jrheum.140694 10.1007/s00296-019-04461-y 10.1001/jama.2010.1768 10.1002/art.25009 10.1002/art.1780270401 10.1093/eurheartj/ehq456 10.1161/ATVBAHA.109.200394 |
| ContentType | Journal Article |
| Copyright | Copyright: © 2023 Nguyen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. COPYRIGHT 2023 Public Library of Science 2023 Nguyen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. info:eu-repo/semantics/openAccess 2023 Nguyen et al 2023 Nguyen et al 2023 Nguyen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: Copyright: © 2023 Nguyen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. – notice: COPYRIGHT 2023 Public Library of Science – notice: 2023 Nguyen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: info:eu-repo/semantics/openAccess – notice: 2023 Nguyen et al 2023 Nguyen et al – notice: 2023 Nguyen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS PYCSY RC3 7X8 3HK 5PM DOA |
| DOI | 10.1371/journal.pone.0281155 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints Gale In Context: Science ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Nursing & allied health premium. Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Database ProQuest Central Technology collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Materials Science Collection ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection Biological Sciences Agricultural Science Database Health & Medical Collection (Alumni) Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic NORA - Norwegian Open Research Archives PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Agricultural Science Database MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals (DOAJ) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Sciences (General) |
| DocumentTitleAlternate | High-sensitivity cardiac troponin T in inflammatory arthritis |
| EISSN | 1932-6203 |
| ExternalDocumentID | 2775220742 oai_doaj_org_article_c450c24821ef4651811c3aff05b9ef14 PMC9916599 10852_103032 A736558359 36763689 10_1371_journal_pone_0281155 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Norway United States |
| GeographicLocations_xml | – name: Norway – name: United States |
| GrantInformation_xml | – fundername: ; grantid: Grant H2/2018 |
| GroupedDBID | --- 123 29O 2WC 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAUCC AAWOE AAYXX ABDBF ABIVO ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CITATION CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IGS IHR IHW INH INR IOV IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 OVT P2P P62 PATMY PDBOC PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PTHSS PV9 PYCSY RNS RPM RZL SV3 TR2 UKHRP WOQ WOW ~02 ~KM 3V. ADRAZ BBORY CGR CUY CVF ECM EIF IPNFZ NPM RIG PMFND 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS RC3 7X8 ESTFP PUEGO 3HK AAPBV ABPTK 5PM N95 |
| ID | FETCH-LOGICAL-c717t-1ad0dec46a2b0a0d1daec21c7fd4deec5b5b1574582325e8dfac5e609783ffd13 |
| IEDL.DBID | M48 |
| ISSN | 1932-6203 |
| IngestDate | Sun Jun 04 06:36:40 EDT 2023 Wed Aug 27 01:29:42 EDT 2025 Thu Aug 21 18:38:35 EDT 2025 Thu Aug 31 07:42:43 EDT 2023 Mon Sep 08 04:02:32 EDT 2025 Fri Jul 25 10:18:51 EDT 2025 Tue Jun 17 21:00:34 EDT 2025 Tue Jun 10 20:22:07 EDT 2025 Fri Jun 27 06:07:53 EDT 2025 Fri Jun 27 05:55:17 EDT 2025 Thu May 22 21:22:26 EDT 2025 Wed Feb 19 02:24:45 EST 2025 Thu Apr 24 22:53:20 EDT 2025 Tue Jul 01 04:08:06 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Language | English |
| License | Copyright: © 2023 Nguyen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c717t-1ad0dec46a2b0a0d1daec21c7fd4deec5b5b1574582325e8dfac5e609783ffd13 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Competing Interests: The authors have declared that no competing interests exist. We confirm that AbbVie does not alter our adherence to all PLOS ONE policies on sharing data and materials. |
| ORCID | 0000-0003-2597-4031 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.pone.0281155 |
| PMID | 36763689 |
| PQID | 2775220742 |
| PQPubID | 1436336 |
| PageCount | e0281155 |
| ParticipantIDs | plos_journals_2775220742 doaj_primary_oai_doaj_org_article_c450c24821ef4651811c3aff05b9ef14 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9916599 cristin_nora_10852_103032 proquest_miscellaneous_2775612242 proquest_journals_2775220742 gale_infotracmisc_A736558359 gale_infotracacademiconefile_A736558359 gale_incontextgauss_ISR_A736558359 gale_incontextgauss_IOV_A736558359 gale_healthsolutions_A736558359 pubmed_primary_36763689 crossref_primary_10_1371_journal_pone_0281155 crossref_citationtrail_10_1371_journal_pone_0281155 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2023-02-10 |
| PublicationDateYYYYMMDD | 2023-02-10 |
| PublicationDate_xml | – month: 02 year: 2023 text: 2023-02-10 day: 10 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, CA USA |
| PublicationTitle | PloS one |
| PublicationTitleAlternate | PLoS One |
| PublicationYear | 2023 |
| Publisher | Public Library of Science PLOS Public Library of Science (PLoS) |
| Publisher_xml | – name: Public Library of Science – name: PLOS – name: Public Library of Science (PLoS) |
| References | D-I Jang (pone.0281155.ref025) 2021; 22 S van der Linden (pone.0281155.ref015) 1984; 27 S Turkmen (pone.0281155.ref006) 2020; 26 N Cohen (pone.0281155.ref023) 2019; 42 BR England (pone.0281155.ref007) 2018; 361 P Welsh (pone.0281155.ref027) 2016; 254 O Schieir (pone.0281155.ref001) 2017; 76 WS Bradham (pone.0281155.ref028) 2012; 7 V Furer (pone.0281155.ref005) 2020; 40 FC Arnett (pone.0281155.ref016) 1988; 31 JS Smolen (pone.0281155.ref019) 2020; 79 GA Karpouzas (pone.0281155.ref009) 2018; 57 YH Rho (pone.0281155.ref026) 2009; 61 E Giannitsis (pone.0281155.ref020) 2010; 56 MT Nurmohamed (pone.0281155.ref008) 2015; 11 W Tillett (pone.0281155.ref014) 2012; 39 JT Saunders (pone.0281155.ref002) 2011; 123 E Giannitsis (pone.0281155.ref021) 2020; 78 L Gossec (pone.0281155.ref017) 2020; 79 P Nagele (pone.0281155.ref003) 2013; 166 THP Nguyen (pone.0281155.ref012) 2021; 16 A Södergren (pone.0281155.ref024) 2015; 42 JA de Lemos (pone.0281155.ref022) 2010; 304 D van der Heijde (pone.0281155.ref018) 2017; 76 S Agewall (pone.0281155.ref011) 2011; 32 G Deyab (pone.0281155.ref013); 12 EM Laufer (pone.0281155.ref010) 2010; 30 J Avouac (pone.0281155.ref004) 2014; 41 |
| References_xml | – volume: 12 start-page: e0169830 issue: 2 ident: pone.0281155.ref013 article-title: Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. publication-title: PLoS ONE doi: 10.1371/journal.pone.0169830 – volume: 79 start-page: 680 issue: 6 year: 2020 ident: pone.0281155.ref017 article-title: EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update. publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2020-217159 – volume: 361 start-page: k1036 year: 2018 ident: pone.0281155.ref007 article-title: Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications publication-title: BMJ doi: 10.1136/bmj.k1036 – volume: 22 start-page: 2719 issue: 5 year: 2021 ident: pone.0281155.ref025 article-title: The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics. publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms22052719 – volume: 16 start-page: e0253793 issue: 6 year: 2021 ident: pone.0281155.ref012 article-title: Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis. publication-title: PLoS ONE. doi: 10.1371/journal.pone.0253793 – volume: 56 start-page: 254 issue: 2 year: 2010 ident: pone.0281155.ref020 article-title: Analytical Validation of a High-Sensitivity Cardiac Troponin T Assay publication-title: Clin Chem doi: 10.1373/clinchem.2009.132654 – volume: 123 start-page: 1367 issue: 13 year: 2011 ident: pone.0281155.ref002 article-title: Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.110.005264 – volume: 31 start-page: 315 issue: 3 year: 1988 ident: pone.0281155.ref016 article-title: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. publication-title: Arthritis Rheum doi: 10.1002/art.1780310302 – volume: 42 start-page: 760 issue: 8 year: 2019 ident: pone.0281155.ref023 article-title: Familial history of heart disease and increased risk for elevated troponin in apparently healthy individuals publication-title: Clin Cardiol doi: 10.1002/clc.23214 – volume: 41 start-page: 248 issue: 2 year: 2014 ident: pone.0281155.ref004 article-title: Inflammation and Disease Activity are Associated with High Circulating Cardiac Markers in Rheumatoid Arthritis Independently of Traditional Cardiovascular Risk Factors publication-title: J Rheumatol doi: 10.3899/jrheum.130713 – volume: 11 start-page: 693 year: 2015 ident: pone.0281155.ref008 article-title: Cardiovascular comorbidity in rheumatic diseases. publication-title: Nat. Rev. Rheumatol doi: 10.1038/nrrheum.2015.112 – volume: 57 start-page: 1080 issue: 6 year: 2018 ident: pone.0281155.ref009 article-title: High-sensitivity cardiac troponin I is a biomarker for occult coronary plaque burden and cardiovascular events in patients with rheumatoid arthritis. publication-title: Rheumatology (Oxford). doi: 10.1093/rheumatology/key057 – volume: 26 start-page: 87 year: 2020 ident: pone.0281155.ref006 article-title: Association of High-Sensitivity Troponin T With Left Ventricular Dysfunction in Ankylosing Spondylitis. publication-title: J Clin Rheumatol. doi: 10.1097/RHU.0000000000000951 – volume: 166 start-page: 325 issue: 2 year: 2013 ident: pone.0281155.ref003 article-title: High-sensitivity cardiac troponin T in prediction and diagnosis of myocardial infarction and long-term mortality after noncardiac surgery publication-title: Am Heart J doi: 10.1016/j.ahj.2013.04.018 – volume: 254 start-page: 167 year: 2016 ident: pone.0281155.ref027 article-title: Effect of IL-6 receptor blockade on high-sensitivity troponin T and NT-proBNP in rheumatoid arthritis publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2016.10.016 – volume: 7 start-page: e38930 issue: 6 year: 2012 ident: pone.0281155.ref028 article-title: High-sensitivity cardiac troponin-I is elevated in patients with rheumatoid arthritis, independent of cardiovascular risk factors and inflammation publication-title: PLoS One doi: 10.1371/journal.pone.0038930 – volume: 76 start-page: 1396 year: 2017 ident: pone.0281155.ref001 article-title: Incident myocardial infarction associated with major types of arthritis in the general population: a systematic review and meta-analysis. publication-title: Ann Dis. doi: 10.1136/annrheumdis-2016-210275 – volume: 76 start-page: 978 issue: 6 year: 2017 ident: pone.0281155.ref018 article-title: 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2016-210770 – volume: 39 start-page: 154 issue: 1 year: 2012 ident: pone.0281155.ref014 article-title: The ClASsification for Psoriatic ARthritis (CASPAR) criteria—a retrospective feasibility, sensitivity, and specificity study. publication-title: J Rheumatol doi: 10.3899/jrheum.110845 – volume: 79 start-page: 685 issue: 6 year: 2020 ident: pone.0281155.ref019 article-title: EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2019-216655 – volume: 78 start-page: 18 year: 2020 ident: pone.0281155.ref021 article-title: Gender-specific reference values for high-sensitivity cardiac troponin T and I in well-phenotyped healthy individuals and validity of high-sensitivity assay designation publication-title: Clin Biochem doi: 10.1016/j.clinbiochem.2019.11.013 – volume: 42 start-page: 935 issue: 6 year: 2015 ident: pone.0281155.ref024 article-title: The Extent of Subclinical Atherosclerosis Is Partially Predicted by the Inflammatory Load: A Prospective Study over 5 Years in Patients with Rheumatoid Arthritis and Matched Controls publication-title: J Rheumatol doi: 10.3899/jrheum.140694 – volume: 40 start-page: 437 year: 2020 ident: pone.0281155.ref005 article-title: Prevalence of high-sensitivity cardiac troponin T in real-life cohorts of psoriatic arthritis and general population: a cross-sectional study. publication-title: Rheumatol Int. doi: 10.1007/s00296-019-04461-y – volume: 304 start-page: 2503 issue: 22 year: 2010 ident: pone.0281155.ref022 article-title: Association of troponin T detectedwith a highly sensitive assay and cardiac structure and mortality risk in the general population publication-title: JAMA doi: 10.1001/jama.2010.1768 – volume: 61 start-page: 1580 issue: 11 year: 2009 ident: pone.0281155.ref026 article-title: Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis publication-title: Arthritis Rheum doi: 10.1002/art.25009 – volume: 27 start-page: 361 issue: 4 year: 1984 ident: pone.0281155.ref015 article-title: Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria publication-title: Arthritis Rheum doi: 10.1002/art.1780270401 – volume: 32 start-page: 404 issue: 4 year: 2011 ident: pone.0281155.ref011 article-title: Troponin elevation in coronary vs. non-coronary disease publication-title: Eur Heart J doi: 10.1093/eurheartj/ehq456 – volume: 30 start-page: 1269 year: 2010 ident: pone.0281155.ref010 article-title: The Extent of Coronary Atherosclerosis Is Associated with Increasing Circulating Levels of High Sensitive Cardiac Troponin T publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.109.200394 |
| SSID | ssj0053866 |
| Score | 2.4207845 |
| Snippet | To investigate whether high-sensitivity cardiac troponin T (hsTnT) correlates to markers of disease activity in inflammatory arthritis (IA), and whether... Objective To investigate whether high-sensitivity cardiac troponin T (hsTnT) correlates to markers of disease activity in inflammatory arthritis (IA), and... Objective To investigate whether high-sensitivity cardiac troponin T (hsTnT) correlates to markers of disease activity in inflammatory arthritis (IA), and... ObjectiveTo investigate whether high-sensitivity cardiac troponin T (hsTnT) correlates to markers of disease activity in inflammatory arthritis (IA), and... |
| SourceID | plos doaj pubmedcentral cristin proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | e0281155 |
| SubjectTerms | Ankylosing spondylitis Antirheumatic Agents Arthritis Arthritis, Rheumatoid Atherosclerosis Biology and Life Sciences Calcium-binding protein Cardiovascular disease Care and treatment Chemiluminescence Complications and side effects Diagnosis Drug Therapy, Combination Electronic components industry Gender Health aspects Health services Humans Immunoassay Inflammation Joint diseases Joints (anatomy) Laboratories Medical research Medicine and Health Sciences Medicine, Experimental Methotrexate Methotrexate - therapeutic use Parameter sensitivity Patients Population Psoriasis Psoriatic arthritis Regression analysis Rheumatoid arthritis Rheumatoid factor Risk factors Treatment Outcome Troponin Troponin T Tumor necrosis factor Tumor Necrosis Factor Inhibitors - therapeutic use Tumor Necrosis Factor-alpha Tumor necrosis factor-TNF |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELXQnrggylcDLRiEBBzSxnbsJMeCqAoSIEGLerMc26ErlWTV7P5_Zmxv1KBK5cB1_ZxVZsb2TDzzhpDXrXfeOe5zJr3LS8PK3ChR5Jwb1hjOnAotWb58VSdn5edzeX6t1RfmhEV64Ci4Q1vKwvKy5sx32Le7ZswK03WFbBvfhRbWvGiKbTAV92BYxUqlQjlRscOkl4PV0PsDOFHBDcLyJRvWUT87kgJz_7Q_L1aXw3iT8_l3DuW1Q-n4PrmXvEl6FN9ih9zx_QOyk9brSN8mUul3D8mACR35iOnqsV8EtcE2LF1jn4R-2dNTuhypSeryjuInWpoucCjWP4RpAExcrGNEgImCVf0Ot_UU5HkRaJIekbPjj6cfTvLUbCG3ENGtc2Zc4bwtleFtYQrHnPGWM1t1rnTeW9nKlskKr9kEl752nbHSq1AG0nWOicdk0YN4dwn1EPKpxpd125iyFsJUwiDbqGsgfqmtz0iWJK97sHPkKJVcY78zwTMitrrQNrGUY7OMSx2u3iqIVqJoNepSJ11mJJ9mrSJLxy3496jmCYsc2-EHsDydLE_fZnkZeYFGomPB6rRT6KNKKHhPIZuMvAoI5NnoMZHnl9mMo_707ec_gH58n4HeJFA3gDisScUT8E7I3zVD7s2QsFvY2fAumvRWKqPmVQUuOH4hgZlbM795-OU0jA_F5LzeD5uIUXhDC5gncVVMkkVCQKFq-N9qtl5mop-P9MuLQHOOkYtsmqf_Q1fPyF0O3imm27NijyzWVxu_D97kun0eNo4_p3h0PA priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELbK9sIFUV5NW8AgJOCQNrbjZHNAqEWtChILKi3qzXJsp12pJNtm9_8z4ziBoAq4rsfZZF7xZGa-IeRV6ayzlruYSWfjVLM01plIYs41KzRnNvMjWT7PsuOz9NO5PF8js74XBssqe5_oHbVtDH4j3-N5DkcFjOTeL65jnBqF2dV-hIYOoxXsOw8xdoesg0uWyYSsHxzOvp70vhmsO8tCA53I2V6Q1-6iqd0uvGnheIRtTcbbVz16VXlE_8FvTxZXTXvbofTP2srfXlZH98m9cMqk-51abJA1Vz8gG8GOW_omgE2_fUgaLPSIWyxj7-ZIUON1xtAlzk-o5zU9pfOW6iBGZyl-uqUhsUOxL8JvA8KA0dp2FKC6oG0_fBafgoJeevikR-Ts6PD0w3EchjDEBiK9Zcy0TawzaaZ5mejEMqud4czklU2tc0aWsmQyx_Sb4NJNbaWNdJlvD6kqy8RjMqmBvZuEOggFs8Kl07LQ6VQInQuNKKS2gLhmalxEosB5VYP-I3ap5ArnoAkeEdHLQpmAXo5DNK6UT8nlEMV0rFUoSxVkGZF42LXo0Dv-QX-AYh5oEXvb_9DcXKhgysqkMjEcbpy5CifJw04jdFUlsixcxdKIPEclUV0j6-BB1H4uMnhOIYuIvPQUiL9RY4HPhV61rfr45ft_EH07GRG9DkRVA-wwOjRVwDMhrteIcmdECV7EjJY3UaV7rrTql73Bzl7Nb19-MSzjRbFor3bNqqPJMHMLNE86qxg4i0CBIpvC_-YjexmxfrxSzy89_DlGNLIotv5-W9vkLofzKBbYs2SHTJY3K_cUzo_L8llwCj8Bt19ynQ priority: 102 providerName: ProQuest |
| Title | High-sensitivity cardiac troponin T is associated with disease activity in patients with inflammatory arthritis |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/36763689 https://www.proquest.com/docview/2775220742 https://www.proquest.com/docview/2775612242 http://hdl.handle.net/10852/103032 https://pubmed.ncbi.nlm.nih.gov/PMC9916599 https://doaj.org/article/c450c24821ef4651811c3aff05b9ef14 http://dx.doi.org/10.1371/journal.pone.0281155 |
| Volume | 18 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELe27oUXxPhaxigGIQEPqWInzscDQtu0MpAYaKyob5FjO1ulkpSmleC_585xI4KK4IGXPNR3bXO-s-98598R8rww2mjNjc-E0X4kWeTLOAx8ziXLJGc6ti1ZPlzE55Po_VRMd8imZ6sTYLM1tMN-UpPlfPT92483YPCvbdeGhG2YRou6MiPYL8HJEbtkz2aMsJgv6vIKYN1x7C7Q_YkTHGFl7avqbVUW0b9btweLed1sc0p_r638ZbMa3yG3nZdJj1u12Cc7prpL9p0dN_SlA5t-dY_UWOjhN1jG3vaRoMrqjKIr7J9QzSp6RWcNlW4ajaZ4dEtdYofivQjLBoQOo7VpKUCYoG1fbRafgoLeWPik-2QyPrs6PfddEwZfQaS38pnUgTYqiiUvAhlopqVRnKmk1JE2RolCFEwkmH4LuTCpLqUSJrbXQ8pSs_ABGVQg3gNCDYSCcWaitMhklIahTEKJKKQ6g7gmVcYjnpN8XoH-I3ap4Dn2QQu5R8LNXOTKoZdjE415blNyCUQxrWhznMvczaVH_I5r0aJ3_IX-BKe5o0XsbftBvbzOnSnnKhKB4vDHmSmxkzxwqlCWZSCKzJQs8sgTVJK8vcjarSD5cRLG8J6hyDzyzFIg_kaFBT7Xct00-buPX_6B6PNlj-iFIyprEIeS7lIFvBPievUoj3qUsIqo3vABqvRGKk3OkwRcczw5Ac6Nmm8fftoN45di0V5l6nVLE2PmFmgetlbRSRaBAsM4hd9NevbSE31_pJrdWPhzjGhElh3-j7l6RG5x8FqxDJ8FR2SwWq7NY_AyV8WQ7CbTBJ7pKcPn-O2Q7J2cXXy6HNpzm6FdWH4CB8-D4Q |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbK9gAXRHk1UKhBIOCQNrbz2Bwq1EKrXfoAlRb1ZhzbaSuVZGm2Qvw5fhszjrMQVAGXXtfjbDIve-yZbwh5VlhjjeE2ZIk1YaxYHKpURCHniuWKM5O6liy7e-noMH53lBzNkR9dLQymVXY-0TlqU2s8I1_lWQZbBYzkXk--htg1Cm9XuxYayrdWMGsOYswXdmzb798ghGvWxm9B3s8539o8eDMKfZeBUEMoMw2ZMpGxOk4VLyIVGWaU1ZzprDSxsVYnRVKwJMP7JcETOzSl0olNXf1DWRom4LnXyHyMBygDMr-xufdhv1sLwJukqS_YExlb9fqxMqkruwIrO2zHsIxKO3uuekuj6yAwWycGk7O6uWwT_Gcu52-L49YtctPvaul6q4YLZM5Wt8mC9xsNfenBrV_dITUmloQNps23fSuodjqq6RT7NVSnFT2gpw1VXm2soXhUTP1FEsU6DDcNCD0mbNNSgKmAdn9xWQMUDOLEwTXdJYdXIo57ZFABexcJtRB6prmNh0Wu4qEQKhMKUU9NDnHUUNuABJ7zsgJ7Q6zUhEvsuyZ4QEQnC6k9Wjo27TiT7gowg6ipZa1EWUovy4CEs1mTFi3kH_QbKOYZLWJ9ux_q82PpXYfUcRJpDi_ObImd62GmFqoso6TIbcnigCyjksi2cHbmseR6JlL4TpHkAXnqKBDvo8KEomN10TRy_P7TfxB93O8RvfBEZQ3s0MoXccA3IY5Yj3KpRwleS_eGF1GlO6408pd9w8xOzS8ffjIbxodikmBl64uWJsWbYqC531rFjLMITCjSIfxv1rOXHuv7I9XpiYNbxwgqyfMHf3-tZXJ9dLC7I3fGe9sPyQ0Oe2FM7mfREhlMzy_sI9i7TovH3kFQ8vmqfdJPaMKxxg |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3dT9UwFG8QEuOLEb-YolSjUR8Ga7uPuwdiQCBc0StBMLzVru3gJrhd2SXGf9G_ynO67uoMUV94XU_3cb7as57zO4Q8K6yxxnAbssSaMFYsDlUqopBzxXLFmUldS5b3o3T3KH57nBzPkR9dLQymVXY-0TlqU2v8R77Gswy2ChjJrZU-LWJ_a-f15GuIHaTwpLVrp6F8mwWz7uDGfJHHnv3-DcK5Zn24BbJ_zvnO9uGb3dB3HAg1hDXTkCkTGavjVPEiUpFhRlnNmc5KExtrdVIkBUsyPGsSPLEDUyqd2NTVQpSlYQLue40sZLDqQyC4sLk92j_o1gXwLGnqi_dExta8rqxO6squwioPWzMsqdLOtqveMum6CczWjPnJWd1ctiH-M6_zt4Vy5xa56Xe4dKNVyUUyZ6vbZNH7kIa-9EDXr-6QGpNMwgZT6NseFlQ7fdV0ir0bqnFFD-m4ocqrkDUUfxtTf6hEsSbDTQNCjw_btBRgNqDpX1wGAQXjOHXQTXfJ0ZWI4x6Zr4C9S4RaCEPT3MaDIlfxQAiVCYUIqCaHmGqgbUACz3lZge0hbmrCJfZgEzwgopOF1B45HRt4nEl3HJhBBNWyVqIspZdlQMLZrEmLHPIP-k0U84wWcb_dhfr8RHo3InWcRJrDizNbYhd7mKmFKssoKXJbsjggK6gksi2inXkvuZGJFL5TJHlAnjoKxP6o0IpO1EXTyOGHT_9B9PGgR_TCE5U1sEMrX9AB34SYYj3K5R4leDDdG15Cle640shftg4zOzW_fPjJbBhvigmDla0vWpoUT42B5n5rFTPOIkihSAfw3KxnLz3W90eq8amDXsdoKsnzB39_rRVyHXyTfDcc7T0kNzhsizHPn0XLZH56fmEfwTZ2Wjz2_oGSz1ftkn4C4LO2Cg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High-sensitivity+cardiac+troponin+T+is+associated+with+disease+activity+in+patients+with+inflammatory+arthritis&rft.jtitle=PloS+one&rft.au=Thao+H+P+Nguyen&rft.au=Morten+Wang+Fagerland&rft.au=Ivana+Hollan&rft.au=Jon+Elling+Whist&rft.date=2023-02-10&rft.pub=Public+Library+of+Science+%28PLoS%29&rft.eissn=1932-6203&rft.volume=18&rft.issue=2&rft.spage=e0281155&rft_id=info:doi/10.1371%2Fjournal.pone.0281155&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_c450c24821ef4651811c3aff05b9ef14 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |